Sanofi is to expand its vaccines manufacturing and build a new research center in its home market of France, as its CEO Paul Hudson looks to move on from a row over its COVID-19 vaccine candidate.
After Vaccines Row, Sanofi Invests In France, Macron To Secure Supplies
CEO Restates Commitment To France
Sanofi’s €610m investment helps row to be forgotten – though Macron will ‘place bets’ on several COVID-19 vaccines, not just France’s homegrown candidate.
